Industry Verticals »

All Categories

Insights »

About TMR »

Periodontal Therapeutics Market

Periodontal Therapeutics Market (Product Type - Systemic Antibiotics (Doxycycline, Minocycline, Metronidazole), Local Antibiotics (Arestin, Atridox, PerioChip); Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-commerce - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market
  • According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027
fa global periodontal therapeutics market

To know the scope of our report Get a Sample on Enteric Periodontal Therapeutics Market 

Rise in Global Burden of Periodontal Diseases: A Key Driver

  • Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population
  • According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.
  • Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.
  • The global cost of lost productivity due to severe periodontitis is estimated to be around US$ 54 Bn per year, while the total economic impact of periodontal diseases accounts for a major component of the US$ 442 Bn direct and indirect cost caused due to oral diseases.

Get a glimpse of the in-depth analysis through our Report Brochure

Surge in Awareness About Oral Health to Augment Global Market

  • Oral health programs work for formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases such as periodontal disease, dental disease, etc.
  • Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment to these diseases still remains unavailable in developing countries due to low priority accorded to these diseases
  • The Global Periodontal Health Project (GPHP) was launched in October 2015 in order to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden associated with these diseases by raising awareness of its impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.
  • The Global Periodontal Health Project aims to make periodontal health a priority issue at the national level by engaging with Ministers of Health, Chief Dental Officers and the local populations, and also increase the disease awareness levels by actively disseminating dental educational promotional tools.

Uninsured Dental Care in Several Developed and Developing Countries to Hamper Global Periodontal Therapeutics Market

  • Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries
  • Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plan. According to the National Association of Dental Plans, over 114 million people in the U.S. were known to be without dental coverage in 2014.

North America to Account for Major Share of Global Periodontal Therapeutics Market

  • North America is projected to account for leading share of the global periodontal therapeutics market due to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in periodontal therapeutics, and presence of key players
  • The periodontal therapeutics market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the health care sector, and rise in interest of key players in expanding presence in the region

Global Periodontal Therapeutics Market: Competitive Landscape

  • This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global periodontal therapeutics market include
    • Den-Mat Holdings, LLC
    • Valeant Pharmaceuticals International, Inc.
    • Dexcel Pharma
    • 3M Company
    • Oral Science
    • Kaken Pharmaceutical Co., Ltd.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Periodontal Therapeutics Market: Key Developments

Key players in the global periodontal therapeutics market have adopted strategies such as regulatory approvals, advanced product development, launch of new products, increase in investments and funds, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global periodontal therapeutics market. Recent developments in line with these strategies by players operating in the global periodontal therapeutics market are:

  • In February 2017, Oral Science announced its decision to launch Fluorimax, a next-generation of fluoride varnishes intended to be used for the treatment of dental caries
  • In November 2016, Kaken Pharmaceutical Co., Ltd. announced that the company’s REGROTH Dental Kit, a medicinal product used for periodontal regeneration was listed on Japan’s National Health Insurance (NHI) drug reimbursement price list

The report on the global periodontal therapeutics market discusses individual strategies followed by company profiles of manufacturers of periodontal therapeutics treatment products. The competitive landscape section has been included in the periodontal therapeutics market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global periodontal therapeutics market.

Global Periodontal Therapeutics Market – Segmentation

Product

Systemic Antibiotics

  • Doxycycline
  • Minocycline
  • Metronidazole
  • Others

Local Antibiotics

  • Arestin
  • Periochip
  • Atridox
  • Others

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Drug Stores

E-Commerce

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of periodontal therapeutics market?

Periodontal therapeutics market is expected to reach US$ 1.1 billion by 2027

What is the anticipated CAGR of the periodontal therapeutics market in the forecast period?

Periodontal therapeutics market is anticipated to expand at a CAGR of 8.8% to 2019 to 2027

What are the key driving factors for the growth of the periodontal therapeutics market?

Periodontal therapeutics market is driven by rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health

Which is the rising prominent segment in the periodontal therapeutics market?

Local Antibiotics Segment to Account for Significant Share of Periodontal Therapeutics Market

Who are the key players in the global periodontal therapeutics market?

Top key players in periodontal therapeutics market are Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Periodontal Therapeutics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Market Outlook

        5.1. Pricing Analysis

        5.2. Pipeline Analysis

        5.3. Re-imbursement Scenario

    6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2027

            6.3.1. Systemic Antibiotics

                6.3.1.1. Doxycycline

                6.3.1.2. Minocycline

                6.3.1.3. Metronidazole

                6.3.1.4. Others

            6.3.2. Local Antibiotics

                6.3.2.1. Arestin

                6.3.2.2. Periochip

                6.3.2.3. Atridox

                6.3.2.4. Others

        6.4. Market Attractiveness, by Product 

    7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Distribution Channel, 2017–2027

            7.3.1. Hospitals Pharmacies

            7.3.2.  Retail Pharmacies

            7.3.3. Drug Stores

            7.3.4. E-Commerce

        7.4. Market Attractiveness Analysis, by Distribution Channel 

    8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Market Attractiveness Analysis, by Region

    9. North America Periodontal Therapeutics Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast By Product, 2017–2027

            9.2.1. Systemic Antibiotics

                9.2.1.1. Doxycycline

                9.2.1.2. Minocycline

                9.2.1.3. Metronidazole

                9.2.1.4. Metronidazole

                9.2.1.5. Others

            9.2.2. Local Antibiotics

                9.2.2.1. Arestin

                9.2.2.2. Periochip

                9.2.2.3. Atridox

                9.2.2.4. Others

        9.3. Market Value Forecast, by Distribution Channel, 2017–2027

            9.3.1. Hospitals Pharmacies

            9.3.2.  Retail Pharmacies

            9.3.3. Drug Stores

            9.3.4. E-Commerce

        9.4. Market Value Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis 

            9.5.1. By Product 

            9.5.2. By Distribution Channel 

            9.5.3. By Country

    10. Europe Periodontal Therapeutics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2027

            10.2.1. Systemic Antibiotics

                10.2.1.1. Doxycycline

                10.2.1.2. Minocycline

                10.2.1.3. Metronidazole

                10.2.1.4. Others

            10.2.2. Local Antibiotics

                10.2.2.1. Arestin

                10.2.2.2. Periochip

                10.2.2.3. Atridox

                10.2.2.4. Others

        10.3. Market Value Forecast, by Distribution Channel, 2017–2027

            10.3.1. Hospitals Pharmacies

            10.3.2.  Retail Pharmacies

            10.3.3. Drug Stores

            10.3.4. E-Commerce

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis 

            10.5.1. By Product 

            10.5.2. By Distribution Channel 

            10.5.3. By Country/Sub-region

    11. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2027

            11.2.1. Systemic Antibiotics

                11.2.1.1. Doxycycline

                11.2.1.2. Minocycline

                11.2.1.3. Metronidazole

                11.2.1.4. Others

            11.2.2. Local Antibiotics

                11.2.2.1. Arestin

                11.2.2.2. Periochip

                11.2.2.3. Atridox

                11.2.2.4. Others

        11.3. Market Value Forecast, by Distribution Channel, 2017–2027

            11.3.1. Hospitals Pharmacies

            11.3.2.  Retail Pharmacies

            11.3.3. Drug Stores

            11.3.4. E-Commerce

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis 

            11.5.1. By Product 

            11.5.2. By Distribution Channel 

            11.5.3. By Country/Sub-region

    12. Latin America Periodontal Therapeutics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2027

            12.2.1. Systemic Antibiotics

                12.2.1.1. Doxycycline

                12.2.1.2. Minocycline

                12.2.1.3. Metronidazole

                12.2.1.4. Others

            12.2.2. Local Antibiotics

                12.2.2.1. Arestin

                12.2.2.2. Periochip

                12.2.2.3. Atridox

                12.2.2.4. Others

        12.3. Market Value Forecast, by Distribution Channel, 2017–2027

            12.3.1. Hospitals Pharmacies

            12.3.2.  Retail Pharmacies

            12.3.3. Drug Stores

            12.3.4. E-Commerce

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis 

            12.5.1. By Product 

            12.5.2. By Distribution Channel 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Periodontal Therapeutics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2027

            13.2.1. Systemic Antibiotics

                13.2.1.1. Doxycycline

                13.2.1.2. Minocycline

                13.2.1.3. Metronidazole

                13.2.1.4. Others

            13.2.2. Local Antibiotics

                13.2.2.1. Arestin

                13.2.2.2. Periochip

                13.2.2.3. Atridox

                13.2.2.4. Others

        13.3. Market Value Forecast, by Distribution Channel, 2017–2027

            13.3.1. Hospitals Pharmacies

            13.3.2.  Retail Pharmacies

            13.3.3. Drug Stores

            13.3.4. E-Commerce

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis 

            13.5.1. By Product 

            13.5.2. By Distribution Channel 

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of companies)

        14.2. Market Share/Position Analysis, by Company, 2018

        14.3. Company Profiles

            14.3.1. 3M Company

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Growth Strategies

                14.3.1.3. SWOT Analysis

            14.3.2. Den-Mat Holdings, LLC 

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Growth Strategies

                14.3.2.3. SWOT Analysis

            14.3.3. Dexcel Pharma

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Growth Strategies

                14.3.3.3. SWOT Analysis

            14.3.4. Kaken Pharmaceutical Co., Ltd.

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Growth Strategies

                14.3.4.3. SWOT Analysis

            14.3.5. Oral Science 

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Growth Strategies

                14.3.5.3. SWOT Analysis

            14.3.6. Valeant Pharmaceuticals International, Inc. 

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Growth Strategies

                14.3.6.3. SWOT Analysis

    List of Tables

    Table 01:Price Competitiveness Between Atridox and Arestin

    Table 02:Global Pipeline Analysis – Periodontal Therapeutics Drugs Market

    Table 03:Global Periodontal Therapeutics Pipeline Drugs Market Size (US$ Mn) Forecast, 2020–2027

    Table 04:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 05:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 06:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 07:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 08:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2017–2027

    Table 09:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 10:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 11:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 12:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 13:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 14:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 15:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 16:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 17:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 18:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 19:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 20:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 21:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 22:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 23:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 24:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 25:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 26:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 27:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 28:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 29:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 30:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 31:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

    Table 32:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

    Table 33:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    List of Figures

    Figure 01: Global Market Revenue, By Product Type (US$ Mn), 2017

    Figure 02: Global Market Revenue (US$ Mn), 2017

    Figure 03: Periodontal Therapeutics Market Share Analysis

    Figure 04: Porter’s Analysis

    Figure 05: Pipeline Drugs Market Forecast, Research Methodology

    Figure 06: Global PerioSept Market Revenue (US$ Mn), 2023–2026

    Figure 07: Global Periodontal Therapeutics Market, by Product Type

    Figure 08: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 09: Global Systemic Antibiotics Market Revenue (US$ Mn) 2017–2027

    Figure 10: Global Local Antibiotics Market Revenue (US$ Mn) 2017–2027

    Figure 11: Periodontal Therapeutics Market Attractiveness Analysis, by Product Type, 2017

    Figure 12: Global Doxycycline Market Revenue (US$ Mn) 2017–2027

    Figure 13: Global Minocycline Market Revenue (US$ Mn) 2017–2027

    Figure 14: Global Metronidazole Market Revenue (US$ Mn) 2017–2027

    Figure 15: Global Others Market Revenue (US$ Mn) 2017–2027

    Figure 16: Periodontal Therapeutics Market Attractiveness Analysis, by Systemic Antibiotics, 

    Figure 17: Global Arestin Market Revenue (US$ Mn) 2017–2027

    Figure 18: Global PerioChip Market Revenue (US$ Mn) 2017–2027

    Figure 19: Global Atridox Market Revenue (US$ Mn) 2017–2027

    Figure 20: Global Others Market Revenue (US$ Mn) 2017–2027

    Figure 21: Periodontal Therapeutics Market Attractiveness Analysis, by Local Antibiotics, 2017

    Figure 22: Global Periodontal Therapeutics Market Value Share Analysis, by Distribution 

    Figure 23: Global Hospital Pharmacies Market Revenue (US$ Mn) 2017–2027

    Figure 24: Global Retail Pharmacies Market Revenue (US$ Mn) 2017–2027

    Figure 25: Global Drug Stores Market Revenue (US$ Mn) 2017–2027

    Figure 26: Global E-Commerce Market Revenue (US$ Mn) 2017–2027

    Figure 27: Periodontal Therapeutics Market Attractiveness Analysis, by Distribution Channel, 

    Figure 28: Global Periodontal Therapeutics Market Value Share Analysis, by Region, 2017 and 2027

    Figure 29: Periodontal Therapeutics Market Attractiveness Analysis, by Region, 2017

    Figure 30: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 31: North America Market Attractiveness Analysis, by Country, 2017

    Figure 32: North America Market Value Share Analysis, by Country, 2018 and 2027

    Figure 33: North America Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 34: North America Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 35: North America Market Attractiveness Analysis, by Product Type, 2017

    Figure 36: North America Market Attractiveness Analysis, by Distribution Channel Type, 2017

    Figure 37: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 38: Europe Market Attractiveness Analysis, by Country, 2017

    Figure 39: Europe Market Value Share Analysis, by Country, 2018 and 2027

    Figure 40: Europe Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 41: Europe Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 42: Europe Market Attractiveness Analysis, by Product Type, 2017

    Figure 43: Europe Market Attractiveness Analysis, by Distribution Channel Type, 2017

    Figure 44: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 45: Asia Pacific Market Attractiveness Analysis, by Country, 2017

    Figure 46: Asia Pacific Market Value Share Analysis, by Country, 2018 and 2027

    Figure 47: Asia Pacific Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 48: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 49: Asia Pacific Market Attractiveness Analysis, by Product Type, 2017

    Figure 50: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2017

    Figure 51: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 52: Latin America Market Attractiveness Analysis, by Country, 2017

    Figure 53: Latin America Market Value Share Analysis, by Country, 2018 and 2027

    Figure 54: Latin America Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 55: Latin America Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 56: Latin America Market Attractiveness Analysis, by Product Type, 2017

    Figure 57: Latin America Market Attractiveness Analysis, by Distribution Channel, 2017

    Figure 58: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 59: Middle East & Africa Market Attractiveness Analysis, by Country, 2017

    Figure 60: Middle East & Africa Market Value Share Analysis, by Country, 2018 and 2027

    Figure 61: Middle East & Africa Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 62: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 63: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2017

    Figure 64: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2017

    Figure 65: Global Periodontal Therapeutics Market Share Analysis By Company (2017)

Copyright © Transparency Market Research, Inc. All Rights reserved

Periodontal Therapeutics Market

Schedule a Call